Fig. 3From: Payload diversification: a key step in the development of antibody–drug conjugatesStructure of antibody–drug conjugates that have reach clinical trials and their payloads (blue) classified regarding their mechanism of action. Notations within the figure: [ADC name], antibody, payloadBack to article page